ID

27452

Descripción

Study ID: 103094 Clinical Study ID: ARI103094 Study Title: ARI103094-Follow-Up Study for REDUCE Study Subjects Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00883909 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: dutasteride Trade Name: Zytefor,Zyfetor,Duagen,Avolve,Avodart,Avidart Study Indication: Neoplasms, Prostate

Palabras clave

Versiones (2)
  1. 15/11/17 15/11/17 -
  2. 26/11/17 26/11/17 -
Titular de derechos de autor

GlaxoSmithKline

Subido en

15 de noviembre de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Concomitant Medications GSK study Prostatic neoplasms NCT00883909

Inglés

Concomitant Medications GSK study Prostatic neoplasms NCT00883909

1 formularios  
Administrative data
Descripción

Administrative data

Session number
Descripción

Session number

Tipo de datos

integer

Subject number
Descripción

Subject number

Tipo de datos

text

Intake of concomitant Medications
Descripción

Intake of concomitant Medications

Were any chronic concomitant medications taken by the subject during the Follow-Up study?
Descripción

Check that either the YES or NO box at the top of the page is selected. • If NO is selected, check that no applicable concomitant medications are present. • If YES is selected, check that at least one applicable concomitant medication is present. If YES, record below.

Tipo de datos

text

Record of Concomitant Medications
Descripción

Record of Concomitant Medications

Drug (Trade name preferred)
Descripción

Check that the drug name (trade name preferred) is spelled correctly. If medication is given to treat a serious adverse event (SAE), then the event must be recorded on the SERIOUS ADVERSE EVENT page(s).

Tipo de datos

text

Dose
Descripción

Dose

Tipo de datos

float

Units
Descripción

Units

Tipo de datos

text

Frequency
Descripción

Frequency

Tipo de datos

text

Route
Descripción

Route

Tipo de datos

text

Date Started
Descripción

Check that either the ‘Date started’ is completed or ‘started Pre-Follow Up Study’ is completed. At least one must be completed, but it is acceptable if both are completed. • If both ‘Date started’ and ‘started Pre-Follow Up Study’ are completed, check that the start date is pre-study.

Tipo de datos

date

Started Pre- Follow Up Study
Descripción

Check that either the ‘Date started’ is completed or ‘started Pre-Follow Up Study’ is completed. At least one must be completed, but it is acceptable if both are completed. • If both ‘Date started’ and ‘started Pre-Follow Up Study’ are completed, check that the start date is pre-study.

Tipo de datos

boolean

Date Stopped
Descripción

Check that either the ‘Date stopped’ box is completed or the ‘continued Post-Follow Up Study’ is completed. Only one must be completed. • Check that the drug start date is before or equal to the drug stop date.

Tipo de datos

date

Continued Post- Follow Up Study
Descripción

Check that either the ‘Date stopped’ box is completed or the ‘continued Post-Follow Up Study’ is completed. Only one must be completed.

Tipo de datos

boolean

Conditions Treated / Indication
Descripción

Indication

Tipo de datos

text

Prophylaxis
Descripción

Prophylaxis

Tipo de datos

text

Was drug administered for an SAE?
Descripción

If the concomitant medication was taken for a serious adverse event (SAE), check that the event is entered on the SERIOUS ADVERSE EVENT page(s) and that the dates are consistent with the event.

Tipo de datos

text

Volver a la parte superior de la página

Similar models

Concomitant Medications GSK study Prostatic neoplasms NCT00883909

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Administrative data
Session number
Item
Session number
integer
Subject number
Item
Subject number
text
Item Group
Intake of concomitant Medications
Item
Were any chronic concomitant medications taken by the subject during the Follow-Up study?
text
concomitant medications intake
Code List
Were any chronic concomitant medications taken by the subject during the Follow-Up study?
CL Item
Yes (Y)
CL Item
No (N)
Item Group
Record of Concomitant Medications
Drug
Item
Drug (Trade name preferred)
text
Dose
Item
Dose
float
Units
Item
Units
text
Frequency
Item
Frequency
text
Route
Item
Route
text
Date Started
Item
Date Started
date
Started Pre- Follow Up Study
Item
Started Pre- Follow Up Study
boolean
Date Stopped
Item
Date Stopped
date
Continued Post- Follow Up Study
Item
Continued Post- Follow Up Study
boolean
Indication
Item
Conditions Treated / Indication
text
Item
Prophylaxis
text
concomitant medications intake
Code List
Prophylaxis
CL Item
Yes (Y)
CL Item
No (N)
Item
Was drug administered for an SAE?
text
concomitant medications intake
Code List
Was drug administered for an SAE?
CL Item
Yes (Y)
CL Item
No (N)
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial